Oncology Drugs Market Research Report, Growth & Forecast

The global FAK Inhibitors market size is predicted to grow from US$ 19.7 million in 2025 to US$ 434 million in 2032; it is expected to grow at a CAGR of 56.6% from 2026 to 2032. In 2024, global FAK in...

The global PDE-3 Inhibitors market size is predicted to grow from US$ 667 million in 2025 to US$ 926 million in 2032; it is expected to grow at a CAGR of 4.9% from 2026 to 2032. PDE-3 inhibitors are a...

The global PDE-4 Inhibitors market size is predicted to grow from US$ 5250 million in 2025 to US$ 7115 million in 2032; it is expected to grow at a CAGR of 4.5% from 2026 to 2032. PDE-4 inhibitors are...

The global HER2 ADC Drugs for Cancer market size is predicted to grow from US$ 7625 million in 2025 to US$ 13720 million in 2032; it is expected to grow at a CAGR of 8.5% from 2026 to 2032. In 2025, g...

The global Nectin-4 ADC Innovative Drugs market size is predicted to grow from US$ 1661 million in 2025 to US$ 3036 million in 2032; it is expected to grow at a CAGR of 8.8% from 2026 to 2032. In 2025...

The global Radioligand Therapy Drugs for Cancer market size is predicted to grow from US$ 3203 million in 2025 to US$ 5447 million in 2032; it is expected to grow at a CAGR of 8.0% from 2026 to 2032....

The global Targeted Therapy Drugs for Cancer market size is predicted to grow from US$ 118360 million in 2025 to US$ 191441 million in 2032; it is expected to grow at a CAGR of 7.6% from 2026 to 2032....

The global Covalent BTK Inhibitors market size is predicted to grow from US$ 7191 million in 2025 to US$ 10040 million in 2032; it is expected to grow at a CAGR of 5.0% from 2026 to 2032. Covalent BTK...

The global Anticancer Biologics market size is predicted to grow from US$ 109033 million in 2025 to US$ 213624 million in 2032; it is expected to grow at a CAGR of 9.6% from 2026 to 2032. Anticancer B...

The global Ifosfamide for Injection market size is predicted to grow from US$ 205 million in 2025 to US$ 302 million in 2032; it is expected to grow at a CAGR of 5.6% from 2026 to 2032. Ifosfamide for...

The global Disitamab Vedotin market size is predicted to grow from US$ 150 million in 2025 to US$ 530 million in 2032; it is expected to grow at a CAGR of 16.9% from 2026 to 2032. Disitamab Vedotin is...

The global Mirvetuximab Soravtansine market size is predicted to grow from US$ 675 million in 2025 to US$ 2040 million in 2032; it is expected to grow at a CAGR of 15.4% from 2026 to 2032. Mirvetuxima...

The global Tisotumab Vedotin market size is predicted to grow from US$ 162 million in 2025 to US$ 375 million in 2032; it is expected to grow at a CAGR of 11.6% from 2026 to 2032. Tisotumab Vedotin is...

The global Trastuzumab Deruxtecan market size is predicted to grow from US$ 4874 million in 2025 to US$ 11026 million in 2032; it is expected to grow at a CAGR of 9.9% from 2026 to 2032. Trastuzumab D...

According to our (Global Info Research) latest study, the global ALK Inhibitors market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of...

According to our (Global Info Research) latest study, the global Cabozantinib Drug market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR...

According to our (Global Info Research) latest study, the global Cadonilimab Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a...

According to our (Global Info Research) latest study, the global Crizotinib Drugs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR...

According to our (Global Info Research) latest study, the global EGFR-TKI market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %duri...

According to our (Global Info Research) latest study, the global Lapatinib Ditosylate Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032...

According to our (Global Info Research) latest study, the global MET TKIs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %duri...

According to our (Global Info Research) latest study, the global Multi-target MET TKIs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a...

According to our (Global Info Research) latest study, the global Neratinib Maleate Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 wit...

According to our (Global Info Research) latest study, the global Oncology API market size was valued at US$ 33800 million in 2025 and is forecast to a readjusted size of US$ 53760 million by 2032 with...

According to our (Global Info Research) latest study, the global Oral Capecitabine market size was valued at US$ 398 million in 2025 and is forecast to a readjusted size of US$ 570 million by 2032 wit...

According to our (Global Info Research) latest study, the global Osimertinib Mesylate Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032...

According to our (Global Info Research) latest study, the global RET Inhibitors market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of...

According to our (Global Info Research) latest study, the global Savolitinib Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CA...

According to our (Global Info Research) latest study, the global Selpercatinib Capsules market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a...

According to our (Global Info Research) latest study, the global Single-target MET TKIs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a...

According to our (Global Info Research) latest study, the global Thalidomide Analogue market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a C...

According to our (Global Info Research) latest study, the global TKIs for Breast Cancer market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a...

The global CD73 and DDR1-Targeted Drugs for Digestive System Tumors market size is predicted to grow from US$ 221 million in 2025 to US$ 414 million in 2032; it is expected to grow at a CAGR of 9.9% f...

The global Postmenopausal Breast Cancer Treatment Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The dr...

The global Antitumor ADC Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. ADC drugs have gradually become...

The global Advanced Liver Cancer Treatment Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The restricti...

The global Chemotherapy Drugs for Neuroblastoma market size is predicted to grow from US$ 136 million in 2025 to US$ 187 million in 2032; it is expected to grow at a CAGR of 4.8% from 2026 to 2032. Ch...

The global Electrostatic Spray Enamel Powder market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States mar...

The global Dipentaerythritol Hexaacrylate market size is predicted to grow from US$ 135 million in 2025 to US$ 181 million in 2032; it is expected to grow at a CAGR of 4.3% from 2026 to 2032. Dipentae...

The global Soft Ballistic Protection Material market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States ma...

HNY Research projects that the Hepatocellular Carcinoma Targeted Drug market size will grow from 987.75 Million USD in 2025 to 1659.05 Million USD by 2031, at an estimated CAGR of 9.03%. The base year...

HNY Research projects that the Castrate Resistant Prostate Cancer Therapeutics market size will grow from 19063.2 Million USD in 2025 to 39875.06 Million USD by 2031, at an estimated CAGR of 13.09%. T...

According to our (Global Info Research) latest study, the global Combination Therapies for Melanoma market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by...

According to our (Global Info Research) latest study, the global Sacituzumab Tirumotecan market size was valued at US$ 206 million in 2025 and is forecast to a readjusted size of US$ 936 million by 20...

HNY Research projects that the Anti-HER2 Therapy market size will grow from 6258.56 Million USD in 2025 to 8446.15 Million USD by 2031, at an estimated CAGR of 5.12%. The base year considered for the...

HNY Research projects that the Targeted Therapy for Brain Cancer market size will grow from 1512.75 Million USD in 2025 to 2766.19 Million USD by 2031, at an estimated CAGR of 10.58%. The base year co...

HNY Research projects that the Kidney Cancer Therapeutics market size will grow from 457.42 Million USD in 2025 to 594.95 Million USD by 2031, at an estimated CAGR of 4.48%. The base year considered f...

HNY Research projects that the Anticancer Drugs market size will grow from 210.21 Million USD in 2025 to 437.43 Million USD by 2031, at an estimated CAGR of 12.99%. The base year considered for the st...

HNY Research projects that the Non-muscle Invasive Bladder Cancer Therapeutics market size will grow from 3772.41 Million USD in 2025 to 5848.77 Million USD by 2031, at an estimated CAGR of 7.58%. The...

HNY Research projects that the Sarcoma Drugs market size will grow from 1018.02 Million USD in 2025 to 1467.84 Million USD by 2031, at an estimated CAGR of 6.29%. The base year considered for the stud...